Multiproduct Resin Reuse for Therapeutic Protein Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chromatography resins used for biopharmaceutical purification are typically dedicated to a single product, leading to underutilization and waste, with no established methods for their reuse in GMP environments, limiting manufacturing flexibility and increasing costs.
Innovation Solution
A multiproduct resin reuse (MRR) strategy is implemented, specifically using anion exchange (AEX) and cation exchange (CEX) chromatography resins, where resins are cleaned with sodium hydroxide and tested for carryover protein reduction to ensure safe reuse for subsequent product purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chromatography resins are dedicated to a single product for purification, then product quality and process reliability are maintained, but resin utilization efficiency decreases and waste increases
Solution Approach 1:
The patent implements multiproduct resin reuse (MRR) methodology that enables single chromatography resins to be used across multiple therapeutic protein products. The resin is systematically reused after validated cleaning and testing protocols, transforming it from a single-use dedicated component to a multi-functional resource that serves multiple purification campaigns while maintaining product quality standards
Solution Approach 2:
The patent establishes protocols to recover and regenerate chromatography resins through controlled cleaning processes using caustic solutions followed by validation testing. Instead of discarding resins after single-use, the system recovers them through systematic cleaning and verifies their suitability for reuse, thereby reducing waste while ensuring product quality through rigorous testing
2Loss of substance
If chromatography resins are reused across multiple products, then resin waste and costs are reduced, but risk of carryover contamination increases
Solution Approach 1:
The patent implements preliminary cleaning and validation actions before resin reuse. The resin undergoes systematic cleaning with caustic solutions and subsequent validation testing to verify absence of carryover contamination before being deployed for the next product purification, thereby preventing harmful carryover while enabling reuse
Solution Approach 2:
The patent establishes feedback mechanisms through rigorous validation testing including analytical methods to detect carryover proteins and process performance monitoring. Test results provide feedback on resin condition, determining whether the resin is suitable for reuse or requires additional cleaning, thereby controlling carryover risk while maximizing resin utilization
3Reliability
If chromatography resins are used for only a fraction of their potential lifetime in GMP settings, then product quality control is simplified, but manufacturing flexibility and cost-efficiency decrease
Solution Approach 1:
The patent implements MRR methodology that creates a universal resin reuse framework applicable across multiple therapeutic protein products in GMP manufacturing. The standardized cleaning and validation protocols enable the same resin to be deployed across different products and manufacturing campaigns, significantly enhancing manufacturing flexibility and resource utilization while maintaining quality control
Solution Approach 2:
The patent systematically manages parameter changes through controlled cleaning conditions (caustic concentration, contact time, temperature) and validation parameters (carryover detection limits, process performance criteria). By controlling these parameters, the system maintains product quality while enabling extended resin usage and manufacturing adaptability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach extends the lifetime of chromatography resins, reduces waste and costs, and enhances manufacturing flexibility by allowing multiple products to be processed on the same resin without compromising product quality, as demonstrated in GMP-scale First-In-Human studies.
Implementation Method 1
Clearance of carryover biological product generated through the production of one product is demonstrated by cleaning the AEX and CEX manufacturing columns with sodium hydroxide to ensure inactivation and degradation of the carryover protein
Implementation Method 2
One such methodology involves the use of ionic exchange resins, such as anion exchange (AEX) and cation exchange (CEX) chromatography
Data Source
AI summary
The present invention provides a method for multiproduct resin reuse (MRR) utilizing ionic exchange chromatography columns. The methods of the invention outline the cleaning steps necessary for reuse as well as the analytical processes used in determining product carryover from production of one product to the next. The invention outlines a successful MRR strategy that can be utilized not just in lab-scale studies, but in a GMP manufacturing setting.